• Please submit all questions concerning webinar content through the Q&A panel.
• Reminder:
• If you have participants watching this webinar at your site, please collect their names and emails.
• We will be distributing a Q&A document in about one week. This document will fully answer questions asked during the webinar and will contain any corrections that we may discover after the webinar. • Primary Site: Pleura, NOS C38.4
• Pleural mesothelium covers the external surface of lungs and the inside of the chest wall
• The pleura is composed of:
• • The patient went on to have an en bloc resection of the primary tumor and left neck dissection.
• Final pathology
• Tumor size-3.4cm
• Tumor extension-Tumor involves the ethmoid sinus, hard palate, and bone of the posterior wall. Margins were negative. • Regional lymph nodes • MCC is a rare and aggressive skin cancer.
• The incidence of MCC is approx. 1500 new U.S. cases annually
• MCC will prove fatal in roughly 1 in 3 patients as compared to 1 in 5 patients with melanoma • Most deaths occur within 3 years of diagnosis. • 71-year old female with hx of CLL.
• Presents with painless mass left forearm. States it is growing quickly. Prior history of melanoma.
• PE reveals a 3.1 cm diameter vibrant red nodular lesion area on left arm.
• No palpable axillary, supraclavicular or cervical LAD.
• Per MD lesion is presumed malignant.
• Pt declines bx; prefers to have one definitive surgical procedure to excise lesion.
Practice Case 4 (cont.....)
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• Patient had wide local excision and sentinel LN biopsy.
• Final Pathology: 2.9 x 1.9 cm ellipse of erythematous skin within which is a 2.2 x 0.8 cm Merkel Cell Ca confirmed on IHC stains. Deep margin was positive. Tumor extended to a depth of 1.5 cm. Additional 2.5cm margin were submitted with no residual tumor, for clear surgical margins.
• there is no mention of metastasis but the patient has been treated with chemotherapy?
